Gapping down
In reaction to earnings/guidance:
- AI -11.4%, SPLK -4.7%, NCNO -2%, DAL -1.6%, EDR -1.4%, NTAP -0.9% (also increases dividend by 4%, authorizes add'l $500 mln for share repurchases)
Other news:
- FEYE -9.3% (to sell FireEye Products business to Symphony Tech for $1.2 bln; authorizes $500 mln share repurchase program)
- PINE -7.4% (stock offering)
- AXU -7.4% (announces C$25 mln bought deal offering)
- SYNH -5.4% (prices secondary offering of 10,851,676 shares by selling shareholders)
- CWK -4.8% (prices offering of 10 mln ordinary shares at $18.75 per share)
- SJ -4% (stock offering)
- CMBM -3.9% (prices secondary offering of 2 mln ordinary shares at $48.00 per share)
- WPRT -3.6% (prices offering of 18.2 mln shares of common stock at $5.50 per share)
- SUMO -3% (to acquire Sensu)
- HHR -2.9% (prices offering by selling shareholders of 4.5 mln ADSs at $37.00 per ADS)
- APPS -2.6% (delays 10-K filing)
- TSLA -2.4% (thousands of cars being recalled for loose brake bolt, according to Reuters)
- BILL -2.2% (stock offering)
- CYD -2.1% (announced that Dr. Thomas Phung Khong Fock resigned as Chief Financial Officer of the Company with effect from June 1)
- FLR -1.8% (breaks ground on CTA project in Chicago)
- AMRN -1.3% (announces presentation of further insights into potential mechanisms of action of icosapent ethyl)
- MKTX -1.2% (provides volume statistics for May 2021)
- SGEN -1.2% (announces long-term results from TUKYSA (tucatinib) pivotal trial in patients with HER2-positive breast cancer)
Analyst comments:
- VERX -5.8% (downgraded to Sell from Neutral at Goldman)
- SPNS -3.6% (downgraded to Sell from Neutral at Goldman)
- BNFT -2.5% (downgraded to Sell from Neutral at Goldman)
- ALL -1.7% (downgraded to Neutral from Buy at Citigroup)